Developer docs
API playgroundTry for free, no card

Search company profiles

InPhamed

Full company profile

uuid003315j

Namestring
InPhamed
Legal namestring
InPhamed
Websiteurl
inphamed.com
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew Delhi, India
HQ citystring
New Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical intelligence, clinical trial analytics, generic drug insights, patent exclusivity tracking, API manufacturer data
Industry2 codes
PRIMARYHLACAIAF
Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code1 code
  • Marketing Research and Public Opinion Polling541910
Product category
Pharmaceutical Intelligence Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Subscription Access to Platform
TypeSubscription Recurring
Description

Customers subscribe to access the InPhamed platform and its suite of products including Generic Insights, Clinical Insights, and consulting services. Subscribers can use a mix of products and custom services as part of their subscription.

inphamed.com
2Custom Consulting Services
TypeProfessional Services
Description

Bespoke consulting engagements delivering custom reports, market forecasts, epidemiology estimates, patent search and analytics, and other project-based professional services.

inphamed.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Subscription-based access to platform and consulting services
ModelSubscriptionBilling cadenceAnnual
Notes

Customers have flexibility to choose a mix of product and custom services as part of their subscription. Specific pricing tiers are not publicly listed.

inphamed.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1InPhamed Generic Insights
Description

Comprehensive solutions to help pharmaceutical companies identify, launch, and manage generic products successfully, including deep analysis on product selection, competitor activity, and protection status.

inphamed.com
+2 more records
Core offering1 text field

InPhamed provides a subscription-based pharmaceutical intelligence platform covering intellectual property, clinical trials, drug treatments, regulatory landscapes, and commercial markets, with three product lines: Generic Insights (drug portfolio building, patent exclusivity tracking, and API manufacturer identification), Clinical Insights (real-time R&D and clinical trial analytics), and Consulting Services (bespoke market intelligence, epidemiology, real-world evidence, and patent analytics). The platform applies AI and advanced analytics to cleaned health data to support product selection, launch planning, and competitive monitoring for pharmaceutical companies, CROs, and API manufacturers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 1000+ drugs tracked for generic launch planning across US, Europe and ROW markets
+2 more records
Product overview1 text field

InPhamed offers a unified pharmaceutical intelligence platform with three integrated products: Generic Insights for market performance, patent, and API manufacturing data; Clinical Insights for real-time R&D and clinical trial analytics; and Consulting Services as an add-on module providing specialized expertise in market intelligence, epidemiology, and patent analytics. The platform serves pharmaceutical companies, clinical research organizations, and API manufacturers with actionable intelligence across intellectual property, clinical trials, drug treatments, regulatory landscapes, and commercial markets.

Product and service1 record
1InPhamed Generic Insights
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Pharma information services arm of Springer Nature offering drug pipelines, clinical trials, and treatment insights. Comparable to InPhamed's clinical and commercial intelligence offerings, particularly for R&D-focused customers.

TypeBroad incumbent
Description

Large-scale data and analytics provider offering pharma intelligence across drug pipelines, clinical trials, epidemiology, and market forecasting. Comparable to InPhamed across clinical and commercial intelligence use cases, but with substantially broader coverage and resources.

TypeBroad incumbent
Description

Global information services and analytics firm covering pharma IP, clinical trials, and competitive intelligence (e.g., Cortellis, Derwent, DRG). Directly comparable as InPhamed targets overlapping use cases for generic launch planning, patent exclusivity analysis, and clinical trial intelligence, but operates at vastly larger scale.

TypeBroad incumbent
Description

Provides clinical trial intelligence (TrialTrove), drug pipeline data (Pharmaprojects), and competitive pharma intelligence via Trialtrove, Sitetrove, and PharmaProjects. Highly comparable to InPhamed's Clinical Insights product and overall pharma intelligence offering.

TypeDirect peer
Description

Pharma industry intelligence platform covering drug pipelines, API sourcing, patents, and competitive intelligence across pharma and biopharma. Closely aligned with InPhamed's generic launch and API manufacturer identification use cases.

TypeRegional player
Description

Provides healthcare commercial intelligence and analytics, primarily focused on the US market. Comparable as an analytics platform serving pharma and life sciences commercial teams, though with a US-centric and broader healthcare focus versus InPhamed's global generic-drug specialization.

7Beacon Targeted Therapies
TypeEmerging player
Description

Niche pharma competitive intelligence platform focused on oncology drug pipelines and competitive landscape analysis. Comparable as an emerging specialty intelligence platform serving pharma customers with curated clinical and commercial data.

TypeDirect peer
Description

Specialty pharma intelligence firm providing drug launch analytics, exclusivity tracking, and API sourcing data for generic and specialty drug manufacturers. Closely aligned with InPhamed's Generic Insights product, and notably InPhamed's co-founder Neetan Gour previously served as Country Director for IPD Analytics in India and APAC.

TypeBroad incumbent
Description

Provides pharma commercial intelligence, including drug forecasts, pipeline analysis, and deal-making data. Comparable to InPhamed's market intelligence and forecasting capabilities, though with deeper coverage in branded drug analytics versus generic focus.

TypeDirect peer
Description

Specialty platform focused on pharmaceutical patent and exclusivity intelligence, including patent expiration tracking and generic launch timing — directly comparable to a core component of InPhamed's Generic Insights product.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InPhamed

Pharmaceutical Intelligence Softwareinphamed.com

InPhamed firmographics

Firmographics
Name
InPhamed
Legal name
InPhamed
Website
https://inphamed.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

InPhamed industry classification

Industry
Product category
Pharmaceutical Intelligence Software
NAICS
Marketing Research and Public Opinion Polling (541910)
akta.pro industry
PRIMARYHLACAIAF
Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Pharmaceutical intelligence
  • Clinical trial analytics
  • Generic drug insights
  • Patent exclusivity tracking
  • API manufacturer data

Where InPhamed is headquartered

Location

Headquarters

HQ city
New Delhi
HQ country
India
HQ region
Asia

Offices1 record

Markets served

InPhamed business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Subscription Access to Platform: Customers subscribe to access the InPhamed platform and its suite of products including Generic Insights, Clinical Insights, and consulting services. Subscribers can use a mix of products and custom services as part of their subscription.
  2. Custom Consulting Services: Bespoke consulting engagements delivering custom reports, market forecasts, epidemiology estimates, patent search and analytics, and other project-based professional services.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSubscription-based access to platform and consulting services

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

InPhamed product offering

Product offering

Core offering

InPhamed provides a subscription-based pharmaceutical intelligence platform covering intellectual property, clinical trials, drug treatments, regulatory landscapes, and commercial markets, with three product lines: Generic Insights (drug portfolio building, patent exclusivity tracking, and API manufacturer identification), Clinical Insights (real-time R&D and clinical trial analytics), and Consulting Services (bespoke market intelligence, epidemiology, real-world evidence, and patent analytics). The platform applies AI and advanced analytics to cleaned health data to support product selection, launch planning, and competitive monitoring for pharmaceutical companies, CROs, and API manufacturers.

Product overview

InPhamed offers a unified pharmaceutical intelligence platform with three integrated products: Generic Insights for market performance, patent, and API manufacturing data; Clinical Insights for real-time R&D and clinical trial analytics; and Consulting Services as an add-on module providing specialized expertise in market intelligence, epidemiology, and patent analytics. The platform serves pharmaceutical companies, clinical research organizations, and API manufacturers with actionable intelligence across intellectual property, clinical trials, drug treatments, regulatory landscapes, and commercial markets.

Differentiator

Problem solved

Functional benefit

Brands

  • InPhamed Generic Insights: Comprehensive solutions to help pharmaceutical companies identify, launch, and manage generic products successfully, including deep analysis on product selection, competitor activity, and protection status.
  • InPhamed Clinical Insights
  • InPhamed Consulting Services

Products and services

  • InPhamed Generic Insights

Quantifiable outcome

  • 1000+ drugs tracked for generic launch planning across US, Europe and ROW markets
  • +2 more outcomes

Companies that use InPhamed

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

InPhamed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

InPhamed partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

InPhamed competitors and assessment

Company assessment

Broad incumbents

  • Adis (Springer Nature): Pharma information services arm of Springer Nature offering drug pipelines, clinical trials, and treatment insights. Comparable to InPhamed's clinical and commercial intelligence offerings, particularly for R&D-focused customers.
  • GlobalData: Large-scale data and analytics provider offering pharma intelligence across drug pipelines, clinical trials, epidemiology, and market forecasting. Comparable to InPhamed across clinical and commercial intelligence use cases, but with substantially broader coverage and resources.
  • Clarivate Analytics: Global information services and analytics firm covering pharma IP, clinical trials, and competitive intelligence (e.g., Cortellis, Derwent, DRG). Directly comparable as InPhamed targets overlapping use cases for generic launch planning, patent exclusivity analysis, and clinical trial intelligence, but operates at vastly larger scale.
  • Citeline (formerly Pharma Intelligence / Informa): Provides clinical trial intelligence (TrialTrove), drug pipeline data (Pharmaprojects), and competitive pharma intelligence via Trialtrove, Sitetrove, and PharmaProjects. Highly comparable to InPhamed's Clinical Insights product and overall pharma intelligence offering.
  • Evaluate Pharma: Provides pharma commercial intelligence, including drug forecasts, pipeline analysis, and deal-making data. Comparable to InPhamed's market intelligence and forecasting capabilities, though with deeper coverage in branded drug analytics versus generic focus.

Direct peers

  • PharmaCircle: Pharma industry intelligence platform covering drug pipelines, API sourcing, patents, and competitive intelligence across pharma and biopharma. Closely aligned with InPhamed's generic launch and API manufacturer identification use cases.
  • IPD Analytics: Specialty pharma intelligence firm providing drug launch analytics, exclusivity tracking, and API sourcing data for generic and specialty drug manufacturers. Closely aligned with InPhamed's Generic Insights product, and notably InPhamed's co-founder Neetan Gour previously served as Country Director for IPD Analytics in India and APAC.
  • DrugPatentWatch: Specialty platform focused on pharmaceutical patent and exclusivity intelligence, including patent expiration tracking and generic launch timing — directly comparable to a core component of InPhamed's Generic Insights product.

Regional players

  • Definitive Healthcare: Provides healthcare commercial intelligence and analytics, primarily focused on the US market. Comparable as an analytics platform serving pharma and life sciences commercial teams, though with a US-centric and broader healthcare focus versus InPhamed's global generic-drug specialization.

Emerging players

  • Beacon Targeted Therapies: Niche pharma competitive intelligence platform focused on oncology drug pipelines and competitive landscape analysis. Comparable as an emerging specialty intelligence platform serving pharma customers with curated clinical and commercial data.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

InPhamed social profiles

Digital presence

InPhamed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InPhamed leadership team

Management profile

Number of profiles

Profiles5 records

InPhamed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InPhamed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InPhamed

What does InPhamed do?

InPhamed provides a subscription-based pharmaceutical intelligence platform covering intellectual property, clinical trials, drug treatments, regulatory landscapes, and commercial markets, with three product lines: Generic Insights (drug portfolio building, patent exclusivity tracking, and API manufacturer identification), Clinical Insights (real-time R&D and clinical trial analytics), and Consulting Services (bespoke market intelligence, epidemiology, real-world evidence, and patent analytics). The platform applies AI and advanced analytics to cleaned health data to support product selection, launch planning, and competitive monitoring for pharmaceutical companies, CROs, and API manufacturers.

Is InPhamed a public or private company?

InPhamed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was InPhamed founded?

InPhamed was founded in 2021. It employs 11 to 50 people.

Where is InPhamed based?

InPhamed is headquartered in New Delhi, India, in the Asia region.

How does InPhamed make money?

Two revenue lines are on record. Subscription Access to Platform is the primary driver. The others are custom Consulting Services.

Who are InPhamed's main competitors?

Broad incumbents on record are Adis (Springer Nature), GlobalData, Clarivate Analytics, Citeline (formerly Pharma Intelligence / Informa) and Evaluate Pharma. Direct peers are PharmaCircle, IPD Analytics and DrugPatentWatch. Definitive Healthcare is listed as a regional player. Beacon Targeted Therapies is listed as an emerging player.

Does InPhamed have an API?

No public API is recorded for InPhamed.

What industry is InPhamed in?

InPhamed's product category is Pharmaceutical Intelligence Software. Its primary akta.pro industry code is HLACAIAF, Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm), with a secondary code of HLACAOAO, Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines). Its NAICS code is 541910.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales